LTS:0R6U (Germany)
Â
Akt. nach Kapitalherabsetzung
€
7.83
(0%)
Nov 29
Business Description
4SC AG
ISIN : DE000A3E5C40
Share Class Description:
LTS:0R6U: Akt. nach KapitalherabsetzungDescription
4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. The geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.21 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -28.06 | |||||
| Beneish M-Score | 48.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -50.2 | |||||
| 3-Year EBITDA Growth Rate | 27.1 | |||||
| 3-Year EPS without NRI Growth Rate | 27 | |||||
| 3-Year FCF Growth Rate | 17.9 | |||||
| 3-Year Book Growth Rate | -48.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.31 | |||||
| Quick Ratio | 1.31 | |||||
| Cash Ratio | 1.18 | |||||
| Days Sales Outstanding | 128.44 | |||||
| Days Payable | 2140 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 79.67 | |||||
| Operating Margin % | -2108.08 | |||||
| Net Margin % | -2097.21 | |||||
| FCF Margin % | -2660.17 | |||||
| ROE % | -152.89 | |||||
| ROA % | -80.51 | |||||
| ROIC % | -982.04 | |||||
| ROC (Joel Greenblatt) % | -44889.8 | |||||
| ROCE % | -110.46 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 217.36 | |||||
| PB Ratio | 72.45 | |||||
| Price-to-Tangible-Book | 111.79 | |||||
| EV-to-EBIT | -9.81 | |||||
| EV-to-EBITDA | -10.55 | |||||
| EV-to-Revenue | 200.38 | |||||
| EV-to-FCF | -7.53 | |||||
| Price-to-Median-PS-Value | 11.34 | |||||
| Price-to-Net-Current-Asset-Value | 111.79 | |||||
| Price-to-Net-Cash | 391.25 | |||||
| Earnings Yield (Greenblatt) % | -10.19 | |||||
| FCF Yield % | -12.51 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
4SC AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.359 | ||
| EPS (TTM) (€) | -0.744 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 7.825 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 7.825 - 7.825 | ||
| Shares Outstanding (Mil) | 10.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
4SC AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
4SC AG Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
4SC AG Frequently Asked Questions
What is 4SC AG(LTS:0R6U)'s stock price today?
The current price of LTS:0R6U is €7.83. The 52 week high of LTS:0R6U is €7.83 and 52 week low is €7.83.
When is next earnings date of 4SC AG(LTS:0R6U)?
The next earnings date of 4SC AG(LTS:0R6U) is .
Does 4SC AG(LTS:0R6U) pay dividends? If so, how much?
4SC AG(LTS:0R6U) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers